The role of cytokines in skin aging

Climacteric

Volumn 16, Issue 5, 2013, Pages 514-521

  Borg, M ^a   Brincat, S ^a   Camilleri, G ^a   Schembri Wismayer, P ^a   Brincat, M ^b   Calleja Agius, J ^a,b  

^a UNIVERSITY OF MALTA   (Malta)

^b MATER DEI HOSPITAL   (Malta)

Author keywords

Collagen; Cutaneous Aging; Cytokines; Interferons; Interleukins; Menopause; TNF

Indexed keywords

3 DEOXYSAPPANCHALCONE; ALPHA INTERFERON; BETA INTERFERON; CELL ADHESION MOLECULE; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; CYSTEINE RICH PROTEIN 61; CYTOKINE; ESTROGEN; GAMMA INTERFERON; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 18; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; PROTEIN BAD; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; STROMELYSIN; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AGING; BINDING AFFINITY; CD4+ T LYMPHOCYTE; COLLAGEN DEGRADATION; COLLAGEN SYNTHESIS; CUTANEOUS PARAMETERS; CYTOKINE RELEASE; DELAYED HYPERSENSITIVITY; DERMATITIS; ENVIRONMENTAL FACTOR; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; INFECTION RISK; KERATINOCYTE; LANGERHANS CELL; MACROPHAGE; MACROPHAGE ACTIVATION; MEMORY T LYMPHOCYTE; MENOPAUSE; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; SENESCENCE; SKIN ATROPHY; SKIN FIBROBLAST; SKIN INFECTION; SKINFOLD THICKNESS; SMOKING; STRATUM CORNEUM; TURNOVER TIME; ULTRAVIOLET B RADIATION; ULTRAVIOLET RADIATION;

CCN INTERCELLULAR SIGNALING PROTEINS; CELL CYCLE; CYTOKINES; FEMALE; HUMANS; INTERFERONS; INTERLEUKINS; KERATINOCYTES; MENOPAUSE; SKIN AGING; SMOKING; TUMOR NECROSIS FACTOR-ALPHA; ULTRAVIOLET RAYS;

EID: 84884492111     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.3109/13697137.2013.802303     Document Type: Review

References (84)

1. Puizina-Ivi ć N. Skin aging. Acta Dermatovenerol Alp Panonica Adriat 2008; 17: 47-54
2. Perricone N. The Wrinkle Cure. New York: Warner Books, 2001: 207
3. Pfeilschifter J, Koditz R, Pfohl M, Schatz H. Changes in proinfl ammatory cytokine activity after menopause. Endocr Rev 2002; 23: 90-199
4. Vitale C, Cornoldi A, Gebara O, et al. Interleukin-6 and flow mediated dilatation as markers of increased vascular infl ammation in women receiving hormone therapy. Menopause 2005; 12 : 552-8
5. Zupan J, Komadina R, Marc J. The relationship between osteoclastogenic and anti-osteoclastogenic pro-infl ammatory cytokines differs in human osteoporotic and osteoarthritic bone tissues. J Biomed Sci 2012; 19: 28
6. Sugimoto M, Yamashita R, Ueda M. Telomere length of the skin in association with chronological aging and photoaging. J Dermatol Sci 2006; 43: 43-7
7. Raine-Fenning N, Brincat M, Muscat-Baron Y. Skin aging and menopause implications for treatment. Am J Clin Dermatol 2003; 4: 371-8
8. Baumann L. Skin ageing and its treatment. J Pathol 2007; 211 : 241-51
9. Martires KJ, Fu P, Polster AM, Cooper KD, Baron ED. Factors that affect skin aging: A cohort-based survey on twins. Arch Dermatol 2009; 145: 1375-9
10. Brincat M, Muscat-Baron Y, Galea R. The menopause. In S haw RW, Soutter WP, Stanton SL, eds. Gynaecology. London: Dhurchill Livingstone, 1997: 373-92
11. Brincat M P, Galea R. Estrogens and skin. In S tudd J, ed. The Management of the Menopause Annual Review 1998. Lancaster, UK: Parthenon Publishing Group Ltd, 1998: 19-25
12. Brincat M, Moniz C F, Kabalan S, et a l. Decline in skin collagen content and metacarpal index after the menopause and its prevention with sex hormone replacement. Br J Obstet Gynaecol 1987; 94: 126-9
13. Brincat M, Versi E, Moniz C F, Magos A, de Trafford J, Studd J W. Skin collagen changes in post-menopausal women receiving different regimens of estrogen therapy. Obstet Gynecol 1987 ; 70: 123-7
14. Utian W H. The menopause and climacteric. In Philipp E, Setchell M, Ginsburg J, eds. Scientific Foundations of Obstetrics and Gynaecology, 4th edn. Oxford: Butterworth-Heinemann Ltd, 1991: 199-207
15. Brincat M, Moniz C F, Studd J W, Darby A J, Magos A, Cooper D. Sex hormones and skin collagen content in postmenopausal women. Br Med J 1983; 287: 1337-8
16. Black M M, Shuster S, Bottoms E. Osteoporosis, skin collagen, and androgen. BMJ 1970; 4: 773-4
17. Goodrich SM, Wood JE. The effect of oestradiol 17ß on peripheral venous distensibility and velocity of venous blood flow. Am J Obstet Gynecol 1966; 96: 407-12
18. Brincat M, Studd J. Skin and the menopause. In S tudd J, Whitehead MI, eds. The Menopause. London: Blackwell Scientific Publications, 1988: 85-101
19. Punnonen R. Effect of castration and peroral therapy on skin. Acta Obstet Gynaecol Scand 1973; 21: S1-44
20. Roupe G. Skin of the aging human being. Lakartidningen 2001; 98: 1091-5
21. Lovell CR, Smolenski KA, Duance VC, Light ND, Young S, Dyson M. Type I and III collagen content and fibre distribution in normal human skin during ageing. Br J Dermatol 1987; 117 : 419-28
22. RittiéL, Fisher GJ. UV-light-induced signal cascades and skin aging. Ageing Res Rev 2002; 1: 705-20
23. Chung JH, Kang S, Varani J, Lin J, Fisher GJ, Voorhees J J. Decreased extracellular-signal-regulated kinase and increased stress-Activated MAP kinase activities in aged human skin in vivo. J Invest Dermatol 2000; 115: 177-82
24. Fisher G J, Kang S, Varani F, et a l. Mechanisms of photoaging and chronological skin aging. Arch Dermatol 2002; 138 : 1462-70
25. Chen W, Borchers AH, Dong Z, Powell MB, Bowden GT. UVB irradiation-induced activator protein-1 activation correlates with increased c-fos gene expression in a human keratinocyte cell line. J Biol Chem 1998; 273: 32176-81
26. Hensley K, Floyd R. Reactive oxygen species and protein oxidation in aging: A look back, alook ahead. Arch Biochem Biophys 2002; 397: 377-83
27. Hu HL, Forsey RJ, Blades TJ, Barratt M E, Parmar P, Powell Jr. Antioxidants may contribute in the fight against ageing: An in vitro model. Mech Ageing Dev 2000; 121: 217-30
28. Giacomoni P, Declercq L, Hellemans L, Maes D. Aging of human skin: Review of a mechanistic model and first experimental data. IUBMB Life 2000; 49: 259-63
29. Quinlan KL, Song IS, Bunnett NW, et al. Neuropeptide regulation of human dermal microvascular endothelial cell ICAM-1 expression and function. Am J Physiol 1998; 275 : D1580-90
30. Feliciani C, Gupta A K, Saucier D N. Keratinocytes and cytokine/ growth factors. Crit Rev Oral Biol Med 1996; 7: 300-18
31. Calleja-Agius J, Muttukrishna S, Jauniaux E. The role of tumour necrosis factor alpha (TNF a) in human female reproduction. Expert Rev Endocrinol Metab 2009; 4: 273-82
32. Bashir MM, Sharma MR, Werth VP. TNF-Alpha production in the skin. Arch Dermatol Res 2009; 301: 87-91
33. Faurschou A. Role of tumor necrosis factor-A in the regulation of keratinocyte cell cycle and DNA repair after ultraviolet-B radiation. Dan Med Bull 2010; 57: B4179
34. Bashir M M, Sharma M R, Werth V P. UVB and proinfl ammatory cytokines synergistically activate TNF-Alpha production in keratinocytes through enhanced gene transcription. J Invest Dermatol 2009; 129: 994-1001
35. Agius E, Lacy K E, Vukmanovic-Stejic M, et a l. Decreased TNF-A synthesis by macrophages restricts cutaneous immunosurveillance by memory CD4 T cells during aging. Exp Med 2009 ; 206: 1929-40
36. Dada LA, Sznajder JI. Mitochondrial Ca2 and ROS take center stage to orchestrate TNF-A-mediated infl ammatory responses. J Clin Invest 2011; 121: 1683-5
37. Laube S. Skin infections and aging. A ging Res Rev 2004; 3 : 69-89
38. Yoshikawa TT. Epidemiology and unique aspects of aging and infectious diseases. Clin Infect Dis 2000; 30: 931-3
39. Vukmanovic-Stejic M, Zhang Y, Cook JE, et al. Human CD4 CD25hi Foxp3 regulatory T cells are derived by rapid turnover of memory populations in vivo. J Clin Invest 2006 ; 116: 2423-33
40. Tiemessen MM, Jagger AL, Evans HG, van Herwijnen MJ, John S, Taams LS. CD4 CD25 Foxp3 regulatory T cells induce alternative activation of human monocytes/macrophages. Proc Natl Acad Sci USA 2007; 104: 19446-51
41. Dixon WG, Watson K, Lunt M, Hyrich K, Silman AJ, Symmons DP. Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-Tumor necrosis factor therapy: Results from the British Society for Rheumatology Biologics Register. Arthritis Rheum 2006; 54: 2368-76
42. Van Duin D, Mohanty S, Thomas V, et al. Age-Associated defect in human TLR-1/2 function. J Immunol 2007; 178: 970-5
43. Renshaw M, Rockwell J, Engleman C, Gewirtz A, Katz J, Sambhara S. Cutting edge: Impaired Toll-like receptor expression and function in aging. J Immunol 2002; 169: 4697-701
44. Van Den Biggelaar A H, Huizinga T W, de Craen A J, et a l. Impaired innate immunity predicts frailty in old age. The Leiden 85-plus study. Exp Gerontol 2004; 39: 1407-14
45. Krabbe K S, Pedersen M, Bruunsgaard H. Infl ammatory mediators in the elderly. Exp Gerontol 2004; 39: 687-99
46. Van Duin D, Shaw A C. Toll-like receptors in older adults. J Am Geriatr Soc 2007; 55: 1438-44
47. Cullell-Young M, Barrachina M, López-López C, et a l. From transcription to cell surface expression, the induction of MHC class II I-A alpha by interferon-gamma in macrophages is regulated at different levels. Immunogenetics 2001; 53 : 136-44
48. Richards A. Kavanagh D, Atkinson JP. Inherited complement regulatory protein deficiency predisposes to human disease in acute injury and chronic infl ammatory states the examples of vascular damage in atypical hemolytic uremic syndrome and debris accumulation in age-related macular degeneration. Adv Immunol 2007; 96: 141-77
49. Pacifici R, Brown C, Puscheck E, et a l. Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc Natl Acad Sci USA 1991; 88: 5134-8
50. Deswal A, Petersen NJ, Feldman AM, Young J B, White BG, Mann DL. Cytokines and cytokine receptors in advanced heart failure: An analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 2001; 103: 2055-9
51. Chou DH, Lee W, McCulloch CA. TNF-Alpha inactivation of collagen receptors: Implications for fibroblast function and fibrosis. J Immunol 1996; 156: 4354-62
52. Youn UJ, Nam KW, Kim HS, et al. 3-Deoxysappanchalcone inhibits tumor necrosis factor-A-induced matrix metalloproteinase-9 expression in human keratinocytes through activated protein-1 inhibition and nuclear factor-kappa B DNA binding activity. Biol Pharm Bull 2011; 34: 890-3
53. Saja K, Babu MS, Karunagaran D, Sudhakaran PR. Antiinfl ammatory effect of curcumin involves downregulation of MMP-9 in blood mononuclear cells. Int Immunopharmacol 2007; 7: 1659-67
54. Crawford HC, Matrisian LM. Mechanisms controlling the transcription of matrix metalloproteinase genes in normal and neoplastic cells. Enzyme Protein 1996; 49: 20-37
55. Ban HS, Suzuki K, Lim SS, et al. Inhibition of lipopolysaccharideinduced expression of inducible nitric oxide synthase and tumor necrosis factor-Alpha by 2-hydroxychalcone derivatives in RAW 264.7 cells. Biochem Pharmacol 2004; 67: 1549-57
56. Yodsaoue O, Cheenpracha S, Karalai C, Ponglimanont C, Tewtrakul S. Anti-Allergic activity of principles from the roots and heartwood of Caesalpinia sappan on antigeninduced beta-hexosaminidase release. Phytother Res 2009; 23 : 1028-31
57. Lee Y M, Jeong G S, Lim H D, An R B, Kim Y C, Kim EC. Isoliquiritigenin 2-methyl ether induces growth inhibition and apoptosis in oral cancer cells via heme oxygenase-1. Toxicol In Vitro 2010; 24: 776-82
58. Liu A L, Shu S H, Qin H L, Lee S M, Wang Y T, Du G H. In vitro anti-influenza viral activities of constituents from Caesalpinia sappan. Planta Med 2009; 75: 337-9
59. Hirao T, Aoki H, Yoshida T, Sato Y, Kamoda H. Elevation of interleukin 1 receptor antagonist in the stratum corneum of sunexposed and ultraviolet B-irradiated human skin. J Invest Dermatol 1996; 106: 1102-7
60. Kligman AM. The biology of the stratum corneum. In The Epidermis. New York: Academic Press, 1964: 387-433
61. Kligman AM. A brief history of how the dead stratum corneum became alive. In Elias PM, Feingold KR, eds. Skin Barrier. New York: Taylor & Francis, 2006: 15-24
62. Dinarello C A. Interleukin 1 and interleukin 18 as mediators of infl ammation and the aging process. Am J Clin Nutr 2006; 83 : S2447-55
63. Garmyn M, Yaar M, Boileau N, Backendorf C, Gilchrest B A. Effect of aging and habitual sun exposure on the genetic response of cultured human keratinocytes to solar-simulated irradiation. J Invest Dermato l 1992; 99: 743-8
64. Kawase Y, Hoshino T, Yokota K, et al. Exacerbated and prolonged allergic and non-Allergic infl ammatory cutaneous reaction in mice with targeted interleukin-18 expression in the skin. J Invest Dermatol 2003; 121: 502-9
65. Schwarz A, Maeda A, St ä nder S, van Steeg H, Schwarz T. IL-18 reduces ultraviolet radiation-induced DNA damage and thereby affects photoimmunosuppression. J Immunol 2006; 176: 2896-901
66. Rose-John S. IL-6 trans-signaling via the soluble IL-6 receptor: Importance for the pro-infl ammatory activities of IL-6. Int J Biol Sci 2012; 8: 1237-47
67. Turksen K, Kupper T, Degenstein L, Williams I, Fuchs E. Interleukin 6: Insights to its function in skin by overexpression in transgenic mice. Proc Natl Acad Sci USA 1992; 89: 5068-72
68. Aragane Y, Yamada H, Schwarz A, et al. Transforming growth factor-Alpha induces interleukin-6 in the human keratinocyte cell line HaCaT mainly by transcription activation. J Invest Dermatol 1996; 106: 1192-7
69. Grossman RM, Krueger J, Yourish D, et al. Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci USA 1989; 86: 6367-71
70. Cohen MC, Cohen S. Cytokine function: A study in biologic diversity. Am J Clin Pathol 1996; 105: 589-98
71. Li J, Farthing PM, Ireland GW, Thornhill MH. IL-1 a and IL-6 production by oral and skin keratinocytes: Similarities and differences in response to cytokine treatment in vitro. J Oral Pathol Med 1996; 25: 157-62
72. Omoigui S. The interleukin-6 infl ammation pathway from cholesterol to aging-role of statins, bisphosphonates and plant polyphenols in aging and age-related diseases. Immun Ageing 2007; 4: 1
73. Moiseeva O, Mallette FA, Mukhopadhyay UK, Moores A, Ferbeyre G. DNA damage signaling and p53-dependent senescence after prolonged beta-interferon stimulation. Mol Biol Cell 2006 ; 17: 1583-92
74. Pammer J, Reinisch C, Birner P, Pogoda K, Sturzl M, Tschachler E. Interferon-Alpha prevents apoptosis of endothelial cells after short-Term exposure but induces replicative senescence after continuous stimulation. Lab Invest 2006; 86: 997-1007
75. Neuber K, Schmidt S, Mensch A. Telomere length measurement and determination of immunosenescence-related markers (CD28, CD45RO, CD45RA, interferon-. and interleukin-4) in skin-homing T cells expressing the cutaneous lymphocyte antigen: Indication of a non-Ageing T-cell subset. Immunology 2003; 109: 24-31
76. Ghersetich I, Lotti T. Alpha-interferon cream restores decreased levels of Langerhans/indeterminate (CD1a) cells in aged and PUVA-Treated skin. Skin Pharmacol 1994; 7: 118-20
77. Quan T, Qin Z, Robichaud P, Voorhees J J, Fisher GJ. CCN1 contributes to skin connective tissue aging by inducing ageassociated secretory phenotype in human skin dermal fibroblasts. J Cell Commun Signal 2011; 5: 201-7
78. Quan T, He T, Shao Y, et a l. Elevated cysteine-rich 61 mediates aberrant collagen homeostasis in chronologically aged and photoaged human skin. Am J Pathol 2006; 169: 482-90
79. Chen CC, Lau LF. Functions and mechanisms of action of CCN matricellular proteins. Int J Biochem Cell Biol 2009; 41 : 771-83
80. Bai T, Chen C, Lau LF. Matricellular protein CCN1 activates a proinfl ammatory genetic program in murine macrophages. J Immunol 2010; 184; 3223-32
81. Jun JI, Lau LF. The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol 2010; 12: 676-85
82. Maggio M, Guralnik JM, Longo DL, Ferrucci L. Interleukin-6 in aging and chronic disease: A magnificent pathway. J Gerontol A Biol Sci Med Sci 2006; 61: 575-84
83. BaugéC, Legendre F, Leclercq S, et al. Interleukin-1beta impairment of transforming growth factor beta1 signaling by down-regulation of transforming growth factor beta receptor type II and up-regulation of Smad7 in human articular chondrocytes. Arthritis Rheum 2007; 56: 3020-32
84. Calleja-Agius J, Muscat-Baron Y, Brincat MP. S kin ageing. Menopause Int 2007; 13: 60-4